![]() |
|
|


Department of Physiology and Cellular Biophysics,
The Center for Radiation Research, and
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY;
Surgical Service, John D. Dingell VA Medical Center and Wayne State University, Detroit, MI; and the
Department of Surgical Pathology, New York Presbyterian Medical Center, New York, NY
**
*
3To whom correspondence should be addressed. E-mail: nje7{at}columbia.edu.
High intakes of dietary fiber or resistant starches have been associated with a lower incidence of colon cancers. Because short-chain fatty acids (SCFA) such as butyrate are produced in the colonic lumen by the bacterial fermentation of dietary fibers and resistant starches, we hypothesized that SCFA may inhibit the development of invasive human colon cancers. To test this hypothesis, primary human invasive colonocytes were isolated from fresh surgical specimens and treated with 0.01 mol/L acetate, propionate or butyrate; cell invasion, cell adhesion, F-actin polymerization, urokinase plasminogen activator (uPA), tissue inhibitor matrix metalloproteinase (TIMP)-1, TIMP-2 and mutant p53, Bcl-2, Bax, p21 and proliferating cell nuclear antigen (PCNA) protein expression levels were examined. Although each of the SCFA tested significantly reduced primary cell invasion, butyrate was the most potent, inhibiting primary invasive human colon cancer invasion by 54% (P < 0.0001). The effects of SCFA on primary cell invasion appeared to be independent of cell adhesion and F-actin polymerization but dependent on the inhibition of uPA (P < 0.05) and the stimulation of TIMP-1 and TIMP-2 activities (P < 0.05). Protein expression levels of mutant p53, p21, Bax, Bcl-2 and PCNA were significantly altered by each of the SCFA tested (P < 0.05). These data indicate that SCFA inhibit invasive human colon cancer by modulating proteolytic uPA and antiproteolytic TIMP-1 and TIMP-2 activities, but their mechanisms of action on tumor suppression, apoptosis and growth arrest may differ.
KEY WORDS: butyrate invasive colon cancer urokinase plasminogen activator dietary fiber gene-nutrient interactions
This article has been cited by other articles:
![]() |
H. Zeng and M. Briske-Anderson Prolonged Butyrate Treatment Inhibits the Migration and Invasion Potential of HT1080 Tumor Cells J. Nutr., February 1, 2005; 135(2): 291 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Li and T. H. Elsasser Butyrate-induced apoptosis and cell cycle arrest in bovine kidney epithelial cells: Involvement of caspase and proteasome pathways J Anim Sci, January 1, 2005; 83(1): 89 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Sanderson Short Chain Fatty Acid Regulation of Signaling Genes Expressed by the Intestinal Epithelium J. Nutr., September 1, 2004; 134(9): 2450S - 2454S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyauchi, E. Gopal, Y.-J. Fei, and V. Ganapathy Functional Identification of SLC5A8, a Tumor Suppressor Down-regulated in Colon Cancer, as a Na+-coupled Transporter for Short-chain Fatty Acids J. Biol. Chem., April 2, 2004; 279(14): 13293 - 13296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Davie Inhibition of Histone Deacetylase Activity by Butyrate J. Nutr., July 1, 2003; 133(7): 2485S - 2493. [Abstract] [Full Text] [PDF] |
||||